Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innoviva Inc (INVA)
NASDAQ:INVA
Holding INVA?
Track your performance easily
INVA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.57 - $21.28
Previous Close$19.06
Volume894.11K
Average Volume (3M)578.15K
Market Cap
$1.19B
Enterprise Value$1.38B
Total Cash (Recent Filing)$260.63M
Total Debt (Recent Filing)$447.81M
Price to Earnings (P/E)27.7
Beta0.38
Next Earnings
Feb 05, 2025EPS Estimate
$0.37Last Dividend Ex-Date
Sep 08, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)0.69
Shares Outstanding62,601,081
10 Day Avg. Volume1,013,278
30 Day Avg. Volume578,146
Standard Deviation0.09
R-Squared0.12
Alpha0.00551
Financial Highlights & Ratios
Price to Book (P/B)1.79
Price to Sales (P/S)3.39
Price to Cash Flow (P/CF)6.10
P/FCF Ratio6.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.91
Enterprise Value/Gross Profit5.15
Enterprise Value/Ebitda18.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Innoviva News
PremiumCompany Announcements
Innoviva Reports Strong Q3 Growth Amidst Strategic AdvancesPremiumPre-Earnings
Innoviva (INVA) Q3 Earnings Cheat Sheet
Ownership Overview
1.07% Insiders
31.73% Mutual Funds
23.55% Other Institutional Investors
9.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INVA FAQ
What was Innoviva Inc’s price range in the past 12 months?
Innoviva Inc lowest stock price was $13.57 and its highest was $21.28 in the past 12 months.
What is Innoviva Inc’s market cap?
Currently, no data Available
When is Innoviva Inc’s upcoming earnings report date?
Innoviva Inc’s upcoming earnings report date is Feb 05, 2025 which is in 74 days.
How were Innoviva Inc’s earnings last quarter?
Innoviva Inc released its earnings results on Nov 06, 2024. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.265 by -$0.245.
Is Innoviva Inc overvalued?
According to Wall Street analysts Innoviva Inc’s price is currently Overvalued.
Does Innoviva Inc pay dividends?
Innoviva Inc pays a Semiannually dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Innoviva Inc dividends here
What is Innoviva Inc’s EPS estimate?
Innoviva Inc’s EPS estimate is $0.37.
How many shares outstanding does Innoviva Inc have?
Innoviva Inc has 62,601,080 shares outstanding.
What happened to Innoviva Inc’s price movement after its last earnings report?
Innoviva Inc reported an EPS of $0.02 in its last earnings report, missing expectations of $0.265. Following the earnings report the stock price went up 0.402%.
Which hedge fund is a major shareholder of Innoviva Inc?
Among the largest hedge funds holding Innoviva Inc’s share is Hussman Strategic Advisors Inc. It holds Innoviva Inc’s shares valued at 2M.
---
Innoviva Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
INVA Sentiment 80%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 23.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.92%
12-Months-Change
Fundamentals
Return on Equity
9.97%
Trailing 12-Months
Asset Growth
3.66%
Trailing 12-Months
Company Description
Innoviva Inc
Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
---
INVA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering INVA
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+18.00%
initiated a buy rating 5 months ago
Copying Louise Chen's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.00% per trade.
---